Literature DB >> 17419251

Surgical treatment of pulmonary metastasis from hepatocellular carcinoma.

Norimasa Koide1, Haruhiko Kondo, Kenji Suzuki, Hisao Asamura, Kazuaki Shimada, Ryosuke Tsuchiya.   

Abstract

BACKGROUND/AIMS: The lung is one of the most common sites of extrahepatic spread from hepatocellular carcinoma (HCC). The aim of this study was to evaluate the efficacy of surgical management in patients with pulmonary metastasis from HCC.
METHODOLOGY: Fourteen patients with pulmonary metastases arising from HCC underwent surgery at the National Cancer Center Hospital between 1980 and 2001. The clinical and pathological data were analyzed retrospectively.
RESULTS: Four patients were still alive and none of them had evidence of recurrent disease. Ten patients had died with recurrent HCC. The postoperative morbidity and mortality rates were low. The mean overall survival was 42.7 months (range, 8-87). The mean survival after initial thoracotomy was 21.6 months (range, 1-66). The 1-, 2-, and 5-year survival rates after metastasectomy were 71.4%, 44.6%, and 26.8%, respectively.
CONCLUSIONS: Surgical treatment is appropriate option in selected patients for pulmonary metastasis arising from HCC, and might prolong survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419251

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.

Authors:  Akifumi Nakamura; Minoru Esaki; Kazuo Nakagawa; Keisuke Asakura; Yoji Kishi; Satoshi Nara; Kazuaki Shimada; Shun-Ichi Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-28

2.  Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.

Authors:  Taro Ohba; Tokujiro Yano; Tsukihisa Yoshida; Daigo Kawano; Shuichi Tsukamoto; Fumihiro Shoji; Akinobu Taketomi; Hideki Saitsu; Sadanori Takeo; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

3.  Pulmonary resection for metastases from hepatocellular carcinoma.

Authors:  Fengshi Chen; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

4.  Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors.

Authors:  Jong-Bum Kwon; Khun Park; Young-Du Kim; Jong-Hee Seo; Seok-Whan Moon; Deog-Gon Cho; Yong-Whan Kim; Dong-Goo Kim; Seung-Kew Yoon; Hyeon-Woo Lim
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

5.  Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma.

Authors:  Tse-Ming Kuo; Kai-Ming Chang; Tsun-I Cheng; Kuo-Jang Kao
Journal:  Liver Cancer       Date:  2017-08-29       Impact factor: 11.740

6.  Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection.

Authors:  Yoji Kishi; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Int J Hepatol       Date:  2011-06-23

7.  Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience.

Authors:  Federica Invenizzi; Massimo Iavarone; Maria Francesca Donato; Alessandra Mazzucco; Massimo Torre; Serena Conforti; Arianna Rimessi; Claudio Zavaglia; Marco Schiavon; Giovanni Comacchio; Federico Rea; Riccardo Boetto; Umberto Cillo; Daniele Dondossola; Luciano De Carlis; Pietro Lampertico; Mario Nosotti; Paolo Mendogni
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

8.  Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.

Authors:  Han Pil Lee; Jae Kwang Yun; Hee Suk Jung; Duk Hwan Moon; Geun Dong Lee; Sehoon Choi; Yong-Hee Kim; Dong Kwan Kim; Seung Il Park; Hyeong Ryul Kim
Journal:  World J Surg Oncol       Date:  2021-01-30       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.